SQ609

Research use only, not for human use.

SQ609 is a potential anti-tuberculosis drug selected from a library of dipiperidine derivatives.

SQ609 is a lead compound from a library of dipiperidines. SQ609 inhibits more than 90% of intracellular bacterial growth at 4μg/ml and is toxic to these cells. SQ609 displays a potent antitubercular activity .

In Mtb-infected macrophages in vitro, SQ609 inhibits more than 90% of intracellular bacterial growth at 4μg/ml and is toxic to these cells.

SQ609 (10 mg/kg; intravenous injection) completely prevents weight loss in the Mtb-infected animals and prolongs the therapeutic effect following drug withdrawal for another 10-15 days.Animal Model:TB susceptible mice (C3H/He)Dosage:10 mg/kg Administration:I.v.Result:Prevented weight loss in the Mtb-infected animals and prolonged the therapeutic effect following drug withdrawal for another 10-15 days.

——

GPCR/G Protein

Antibacterial

Antibacterial

——

——

627052-25-9

346.55

C22H38N2O

>98% (HPLC)

In Vitro:?DMSO : 6.67 mg/mL (19.25 mM; Ultrasonic (<60°C)

OC1CCN(CC2CCN(CC34CC5CC(CC(C5)C3)C4)CC2)CC1

——

(-20℃)

With Ice Pack

≥ 2 years